Navigation Links
Dacogen in Medical News

SuperGen Reports 2008 Fourth Quarter and Year-End Financial Results

...at December 31, 2007. 2009 Financial Guidance The initial financial guidance for 2009 is as follows: Royalty revenue for dacogen is expected to increase up to 10% from the prior year to a range from $38 million to $42 million. Research and development expenses are expect...

Eisai Will Initiate First Head-to-Head Study Comparing Dacogen(R) (decitabine for injection) and Vidaza(R) (azacitidine) in Patients with Myelodysplastic Syndromes

...ings from this trial could help clarify the fundamental differences between dacogen and Vidaza and ultimately help clinicians with treatment selection," said D...w cases of MDS are diagnosed annually in the United States. About dacogen (R) Dacogen(R) (decitabine for injection) was approved by the U.S....

Dacogen comes to the rescue of MDS

... the body. Typical symptoms include weakness, fatigue, infections, easy bruising, bleeding, and fever. Hence the Food and Drug Administration approved dacogen injections for the treatment of MDS. These injections promote the normal development of blood cells. The FDA has given the drug an orphan drug sta...
Dacogen in Medical Technology

FDA Accepts sNDA for Alternative Dosing Regimen for Dacogen(R) (decitabine for injection) to Treat Patients with Myelodysplastic Syndromes (MDS)

...duction of functional blood cells. Currently, dacogen is approved for use as a three-day regimen, admini...linical development programs we have committed for dacogen and is a vital part of our human health care mis...to be sufficiently complete to review. About dacogen The safety profile of decitabine for injecti...

Dacogen(R) (decitabine for injection) Data Presented on a Phase II Clinical Trial in Elderly Patients with Acute Myeloid Leukemia (AML)

...rom our ongoing, global Phase III trial evaluating dacogen in elderly AML patients," said Edward B. Rubenstei...day support our commitment to continue to evaluate dacogen as a treatment option for elderly patients with AM...opulation and we look forward to seeing additional dacogen results reported." Besides myelosuppressi...

Eisai Provides Preliminary Efficacy Update On EORTC Phase III Trial of Dacogen(R) Versus Supportive Care in Patients With Myelodysplastic Syndromes

...ilar to those observed in other clinical trials of dacogen in patients with MDS. In the trial, conducted by t... for the Research and Treatment of Cancer (EORTC), dacogen was administered on a three-day dosing schedule. I...ase II trial (DACO-020) in which patients received dacogen every day for five days. The regimen was repeated ...

SuperGen Comments on Preliminary Efficacy Update on EORTC Phase 3 Trial of Dacogen(R) Versus Supportive Care in Patients With Myelodysplastic Syndromes

...monstrate a statistically significant advantage of dacogen treatment on median survival compared to BSC, the ...ilar to those observed in other clinical trials of dacogen in patients with MDS. The trial, conducted by the ...arch and Treatment of Cancer (EORTC), administered dacogen on a three-day dosing schedule in which the number...

Eisai's Commitment to Oncology Demonstrated by Clinical Data to be Presented at ASCO Annual Meeting

...or full prescribing information. About Dacogen dacogen (decitabine) for Injection was approved by the U.S...ational Prognostic Scoring System (IPSS) groups. dacogen may cause fetal harm when administered to a pregna...t to father a child while receiving treatment with dacogen and for two months afterwards. The most commonly o...

MGI Pharma, Inc. Summarizes Data Presented at the 2007 American Society of Clinical Oncology (ASCO) Annual Meeting

...ociety of Clinical Oncology (ASCO) Annual Meeting. dacogen (decitabine) for Injection was the subject of five... Dacogen(R) for Injection Study of Response to dacogen in Older Patients Diagnosed with Acute Myelogenous Leukemia (AML) The impact of dacogen on the survival of older patients with AML was pre...

MGI Pharma Summarizes Data Presented at the 2007 American Society of Clinical Oncology (ASCO) Annual Meeting

... Dacogen(R) for Injection Study of Response to dacogen in Older Patients Diagnosed with Acute Myelogenous Leukemia (AML) The impact of dacogen on the survival of older patients with AML was pre...teria. In the 33 patients treated with intravenous dacogen (100-150 mg/m2/course), an overall response rate r...
Dacogen in Biological Technology

SuperGen Reports 2008 Second Quarter Financial Results

... Quarterly dacogen Royalty Revenue Increases 76% from Same Prior Year... a Phase 3 trial, initiated in 2002, comparing dacogen to best supportive care (BSC) in elderly patie...trate a statistically significant advantage of dacogen treatment on median survival compared to BSC, the ...

SuperGen Reports 2008 First Quarter Financial Results

... dacogen Royalty Revenue Increases 114% from Same Prior Year Period DUBLIN, Calif....on schedule to begin Phase 1 clinical trials with SGI-1776 before year-end. dacogen royalty revenues have continued to largely offset our operating expenses an...

SuperGen Reports 2007 Fourth Quarter and Annual Financial Results

...re, compared with a net loss of $16.5 million, or $0.31 per fully diluted share, for the same prior year period. Highlights for 2007 include: -- dacogen royalty revenue was $22.3 million compared to $3.4 million for 2006. -- A major contributor to net income during 2007 was the gain on disposi...
Other Tags
(Date:7/4/2015)... (PRWEB) , ... July 04, 2015 , ... ... the solar industry’s leading recognition of technical sales expertise from the North American ... Technical Sales ProfessionalTM. NABCEP is the most highly respected and well established national ...
(Date:7/3/2015)... ... July 03, 2015 , ... ... its 2015 Annual Conference , the premiere continuing education and networking ... Orlando at SeaWorld in Orlando, Florida. Speakers include the leading rheumatology experts ...
(Date:7/3/2015)... ... July 03, 2015 , ... ... providers, has been retained to lead a national chief nursing officer recruitment ... executive search firms in the healthcare industry, B. E. Smith has recently placed ...
(Date:7/3/2015)... (PRWEB) , ... July 03, 2015 , ... Jennifer Renee ... First Choice Emergency Room , the largest network of independent freestanding emergency rooms in ... facility medical director of our Sienna Plantation facility,” said Executive Medical Director of First ...
(Date:7/3/2015)... Red Deer, Alberta (PRWEB) , ... July 03, 2015 , ... ... Camp host their 24-Hour Train-a-Thon where they provide members of the Red Deer community ... This year’s full day of fitness training, games, food, events and entertainment raised thousands ...
Breaking Medicine News(10 mins):Health News:Local Solar Professional Earns Industry's Most Prestigious Certification 2Health News:Local Solar Professional Earns Industry's Most Prestigious Certification 3Health News:RNS Announces Sessions and Speaker Lineup for the 2015 Annual Conference of the Rheumatology Nurses Society 2Health News:RNS Announces Sessions and Speaker Lineup for the 2015 Annual Conference of the Rheumatology Nurses Society 3Health News:Jane Phillips Medical Center Retains B. E. Smith to Recruit New Chief Nursing Officer 2Health News:Jane Phillips Medical Center Retains B. E. Smith to Recruit New Chief Nursing Officer 3Health News:Dr. Jennifer Renee Hanes Named by First Choice Emergency Room as Medical Director of Missouri City, TX Facility 2Health News:Dr. Jennifer Renee Hanes Named by First Choice Emergency Room as Medical Director of Missouri City, TX Facility 3Health News:Red Deer Fitness Studio Raises $10,000 for Charity Organization with 24-Hour Train-a-Thon 2Health News:Red Deer Fitness Studio Raises $10,000 for Charity Organization with 24-Hour Train-a-Thon 3
(Date:6/23/2015)... N.C. , June 23, 2015   ... today announced the results of a recent study ... accuracy on the wrist during activity. In a ... technology was compared along with the Apple Watch ... accurately measuring heart rate during activity. The study ...
(Date:6/17/2015)... Germany , June 17, 2015 ... today launched new Investigator ® STR assay kits for ... the United States . The new genetic fingerprint kits ... markers (short tandem repeats or STRs) for DNA matching. They ... quality of DNA in each sample, a novel QIAGEN technology ...
(Date:6/16/2015)... June 16, 2015 Fingerprint Cards has ... sensors in the company,s portfolio from one of its module ... to mainly take place during the third quarter 2015. The ... Asia . Jörgen Lantto, CEO of FPC, ... the   growing interest from smartphone OEMs in integrating touch ...
Breaking Biology News(10 mins):Valencell Delivers Breakthrough Heart Rate Accuracy on the Wrist 2Valencell Delivers Breakthrough Heart Rate Accuracy on the Wrist 3QIAGEN Launches New Genetic Fingerprinting Kits for U.S. Forensic Labs 2QIAGEN Launches New Genetic Fingerprinting Kits for U.S. Forensic Labs 3QIAGEN Launches New Genetic Fingerprinting Kits for U.S. Forensic Labs 4QIAGEN Launches New Genetic Fingerprinting Kits for U.S. Forensic Labs 5FPC Receives Order for Touch Fingerprint Sensors of 375 MSEK 2
Other Contents